Todd W. Kelley

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi et al. · Cancer Cell · 2014 · 366 citations · Full text

Medicine, Molecular Biology, Oncology +7

Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

Christopher A. Eide, Matthew S. Zabriskie, Samantha L. Savage et al. · Cancer Cell · 2019 · 245 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships

Jamshid S. Khorashad, Todd W. Kelley, Philippe Szankasi et al. · Blood · 2012 · 223 citations

Medicine, Molecular Biology, Oncology +14

Macrophage Colony-stimulating Factor Promotes Cell Survival through Akt/Protein Kinase B

Todd W. Kelley, Mandy M. Graham, Andrea I. Doseff et al. · Journal of Biological Chemistry · 1999 · 172 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next-Generation Sequencing Data

David H. Spencer, Haley Abel, Christina M. Lockwood et al. · Journal of Molecular Diagnostics · 2012 · 141 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16